Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Physician Payment Sunshine Act finally goes to OMB. FDA signs regulatory agreements with Brazil, Australia and Canada. More regulatory news.

You may also be interested in...



Regulatory Briefs: Guidance On Distributing Publications On Unapproved Uses; Export Certification Updates

FDA issues a revised draft guidance on distributing scientific publications on unapproved new uses of medical products. The agency enhances its export certification and tracking system. More regulatory news.

Brazilian Presidential Decree Opens Door To Less Stringent GMP Certification Requirements For Foreign Firms

New decree opens door to more lenient good manufacturing practice certification requirements than are currently imposed on international medical device manufacturers seeking to gain market entry in Brazil.

Brazilian Presidential Decree Opens Door To Less Stringent GMP Certification Requirements For Foreign Firms

New decree opens door to more lenient good manufacturing practice certification requirements than are currently imposed on international medical device manufacturers seeking to gain market entry in Brazil.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT031791

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel